Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Close-up shot of Rivian R1T_ Image by Trong Nguyen via Shutterstock_
RIVN Stock Pops as Rivian Raises Delivery Outlook Barchart - Thu Jul 2, 3:27PM CDT

Rivian stock rallies on better-than-expected Q2 deliveries and raised full-year outlook. Canaccord reiterated its bullish view on RIVN shares today.

TLSA : 1.0000 (-1.48%)
RIVN : 17.76 (+3.02%)
Aquestive Therapeutics Announces Leadership Expansion to Support Growth GlobeNewswire - Tue Nov 4, 2025

Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives  ...

TLSA : 1.0000 (-1.48%)
AQST : 4.04 (+2.41%)
Tiziana Life Sciences Reports Interim Results and Expands U.S. Presence Tipranks - Sat Oct 4, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tiziana Life...

TLSA : 1.0000 (-1.48%)
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week Stocktwits - Sun Mar 2, 2025

New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.

TLSA : 1.0000 (-1.48%)
AIM : 0.2490 (-0.40%)
PEPG : 2.12 (-3.64%)
AEON : 0.2880 (-0.35%)
MBRX : 2.15 (+0.47%)
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Quiver Quantitative, Inc. - Wed Dec 4, 2024

Tiziana Life Sciences expands Phase 2 trial for intranasal foralumab in non-active secondary progressive multiple sclerosis across prominent Northeast institutions.Quiver AI SummaryTiziana Life Sciences,...

TLSA : 1.0000 (-1.48%)
Tiziana Life Sciences Receives ALS Association Grant to Advance Clinical Trial of Intranasal Foralumab for ALS Treatment Quiver Quantitative, Inc. - Tue Nov 19, 2024

Tiziana Life Sciences receives funding from the ALS Association for a clinical trial of intranasal foralumab in ALS patients.Quiver AI SummaryTiziana Life Sciences, a biotechnology company focused on immunomodulation...

TLSA : 1.0000 (-1.48%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises FinancialNewsMedia - Tue Jun 11, 2024

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TGTX : 53.95 (-0.02%)
TLSA : 1.0000 (-1.48%)
LLY : 1,175.41 (+2.49%)
RHHBY : 51.1400 (+0.27%)
BIIB : 203.16 (+1.61%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises GlobeNewswire - Tue Jun 11, 2024

TGTX : 53.95 (-0.02%)
TLSA : 1.0000 (-1.48%)
LLY : 1,175.41 (+2.49%)
RHHBY : 51.1400 (+0.27%)
BIIB : 203.16 (+1.61%)

Barchart Exclusives

This High-Yield Bank Stock Just Raised Its Dividend by 11% Barchart - Tue Jul 21, 6:30PM CDT
Wells Fargo announced plans to raise its dividend by 11% to $0.50 per share from $0.45 after the Federal Reserve’s stress test showed its CET1 ratio remaining well above requirements. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.